Cargando…

P1647: CHRONIC INFLAMMATORY DISEASES INCREASE THE RISK OF POST-THROMBOTIC SYNDROME: A PROSPECTIVE COHORT STUDY

Detalles Bibliográficos
Autores principales:	Iding, Aaron F.J., Limpens, Thibaut, Ten Cate, Hugo, Ten Cate-Hoek, Arina J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430184/ http://dx.doi.org/10.1097/01.HS9.0000973460.75342.87

Ejemplares similares

P1643: FIBRIN CLOT PROPERTIES IDENTIFY PATIENTS THAT BENEFIT FROM CATHETER-DIRECTED THROMBOLYSIS: A POST HOC ANALYSIS OF THE CAVA TRIAL
por: Iding, Aaron F.J., et al.
Publicado: (2023)

Prevention and treatment of the post‐thrombotic syndrome
por: ten Cate‐Hoek, Arina J.
Publicado: (2018)

Residual Venous Obstruction as an Indicator of Clinical Outcomes following Deep Vein Thrombosis: A Management Study
por: Iding, Aaron F. J., et al.
Publicado: (2023)

The IDEAL DVT study, individualised duration elastic compression therapy against long-term duration of therapy for the prevention of post-thrombotic syndrome: protocol of a randomised controlled trial
por: ten Cate-Hoek, Arina J, et al.
Publicado: (2014)

Postinterventional antithrombotic management after venous stenting of the iliofemoral tract in acute and chronic thrombosis: A systematic review
por: Notten, Pascale, et al.
Publicado: (2021)

Risk factors for recurrence in deep vein thrombosis patients following a tailored anticoagulant treatment incorporating residual vein obstruction
por: Nagler, Michael, et al.
Publicado: (2018)

Using the Functional Resonance Analysis Method to explore how elastic compression therapy is organised and could be improved from a multistakeholder perspective
por: Schreurs, Rachel Hellen Petra, et al.
Publicado: (2021)

Development of a Consensus-Based Cross-Domain Protocol for the Management of Elastic Compression Stocking Therapy in Patients With Deep Venous Thrombosis and Chronic Venous Disease: A Modified Delphi Study
por: Schreurs, Rachel H. P., et al.
Publicado: (2022)

Budget Impact of Three Improvement Targets for Compression Therapy for Patients with Deep Venous Thrombosis in The Netherlands
por: Schreurs, Rachel H. P., et al.
Publicado: (2023)

Calibrated Automated Thrombinography (CAT), a Tool to Identify Patients at Risk of Bleeding during Anticoagulant Therapy: A Systematic Review
por: Zwaveling, Suzanne, et al.
Publicado: (2018)

Prediction of bleeding risk in patients taking vitamin K antagonists using thrombin generation testing
por: Bloemen, Saartje, et al.
Publicado: (2017)

Screen or not to screen for peripheral arterial disease: guidance from a decision model
por: Vaidya, Anil, et al.
Publicado: (2014)

Prevalence of venous obstructions in (recurrent) venous thromboembolism: a case-control study
por: Notten, Pascale, et al.
Publicado: (2020)

Plasma Biomarkers to Predict Cardiovascular Outcome in Patients With Peripheral Artery Disease: A Systematic Review and Meta-Analysis
por: Kremers, Bram, et al.
Publicado: (2020)

Postoperative thromboembolic prophylaxis in joint replacement surgery: Guidelines and daily practice
por: ten Cate-Hoek, Arina J, et al.
Publicado: (2012)

Predicting Recurrent Venous Thromboembolism in Patients With Deep-Vein Thrombosis: Development and Internal Validation of a Potential New Prediction Model (Continu-8)
por: Nagler, Michael, et al.
Publicado: (2021)

Increased Clot Formation in the Absence of Increased Thrombin Generation in Patients with Peripheral Arterial Disease: A Case–Control Study
por: Kleinegris, Marie-Claire F., et al.
Publicado: (2017)

1647. Breast Tuberculosis: A Diagnostic Challenge
por: Hammami, Fatma, et al.
Publicado: (2020)

Lüneberg 1647
Publicado: (1995)

A realist evaluation to identify targets to improve the organization of compression therapy for deep venous thrombosis- and chronic venous disease patients
por: Schreurs, Rachel H. P., et al.
Publicado: (2022)

CAVA (Ultrasound‐Accelerated Catheter‐Directed Thrombolysis on Preventing Post‐Thrombotic Syndrome) Trial: Long‐Term Follow‐Up Results
por: Notten, Pascale, et al.
Publicado: (2021)

The daily practice of direct oral anticoagulant use in patients with atrial fibrillation; an observational cohort study
por: Gulpen, Anouk J. W., et al.
Publicado: (2019)

Colorectal cancer and cardiovascular disease: A thrombo-inflammatory link?
por: ten Cate, Hugo
Publicado: (2021)

Searching for a Common Thrombo-Inflammatory Basis in Patients With Deep Vein Thrombosis or Peripheral Artery Disease
por: Kremers, Bram M. M., et al.
Publicado: (2019)

Comparison of three generic quality-of-life metrics in peripheral arterial disease patients undergoing conservative and invasive treatments
por: Petersohn, Svenja, et al.
Publicado: (2019)

Detecting clinically relevant rivaroxaban or dabigatran levels by routine coagulation tests or thromboelastography in a cohort of patients with atrial fibrillation
por: Henskens, Yvonne M. C., et al.
Publicado: (2018)

Pleiotropic actions of factor Xa inhibition in cardiovascular prevention: mechanistic insights and implications for anti-thrombotic treatment
por: ten Cate, Hugo, et al.
Publicado: (2020)

Quality of anticoagulant therapy and the incidence of in‐stent thrombosis after venous stenting
por: Notten, Pascale, et al.
Publicado: (2020)

Inadequate response to antiplatelet therapy in patients with peripheral artery disease: a prospective cohort study
por: Kremers, B. M. M., et al.
Publicado: (2023)

Rivaroxaban plus aspirin for the prevention of ischaemic events in patients with cardiovascular disease: a cost-effectiveness study
por: Petersohn, Svenja, et al.
Publicado: (2020)

A known unknown? Pharmacological prevention of venous thromboembolism in nursing home residents
por: Brüggemann, Renée A. G., et al.
Publicado: (2021)

Integrating Mechanisms in Thrombotic Peripheral Arterial Disease
por: Nagy, Magdolna, et al.
Publicado: (2022)

New oral anticoagulants: discussion on monitoring and adherence should start now!
por: ten Cate, Hugo
Publicado: (2013)

Dabigatran and apolipoprotein B
por: ten Cate, Hugo
Publicado: (2016)

Thrombosis management in times of COVID-19 epidemy; a Dutch perspective
por: ten Cate, Hugo
Publicado: (2020)

Surviving Covid-19 with Heparin?
por: ten Cate, Hugo
Publicado: (2021)

Thrombosis: Grand Challenges Ahead!
por: ten Cate, Hugo
Publicado: (2021)

Editorial: Insights in thrombosis: 2021
por: ten Cate, Hugo
Publicado: (2022)

P1647: CONTRIBUTION OF NEXT GENERATION FLOW (NGF) CYTOMETRY IN PRIMARY IMMUNE THROMBOCYTOPENIA (ITP): UTILITY FOR THE DIFFERENTIAL DIAGNOSIS WITH MYELODYSPLASTIC SYNDROMES
por: Gonzalez-Lopez, T. J., et al.
Publicado: (2022)

Mortality and the Use of Antithrombotic Therapies Among Nursing Home Residents with COVID‐19
por: Brouns, Steffie H., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1k0ga92h1eccc146a4fgbphnvg